Form 4 for CAI Caris Life Sciences, Inc.
Accepted 2026-03-10 00:00:00 ET · period of report 2026-03-06 · accession 0002072013-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-10 | 2026-03-06 | CAI | Power Luke Thomas | See Remarks | A - Grant | $0.00 | +64.0K | 163.5K | +64% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-06 | A | A | 63,971 | $0.00 | 163,542 | D | — | — | (F1) Represents an award of restricted stock units which vest in accordance with the applicable grant agreement. |